Armistice Capital, LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:56 pm Sale | 2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 188,438 4.990% | -131,318 (-41.07%) | Filing |
| 2024-11-14 5:03 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 319,756 9.990% | 319,756 (New Position) | Filing |